These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25567760)

  • 1. Increased brain uptake of venlafaxine loaded solid lipid nanoparticles by overcoming the efflux function and expression of P-gp.
    Zhou Y; Zhang G; Rao Z; Yang Y; Zhou Q; Qin H; Wei Y; Wu X
    Arch Pharm Res; 2015 Jul; 38(7):1325-35. PubMed ID: 25567760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration.
    Martins SM; Sarmento B; Nunes C; Lúcio M; Reis S; Ferreira DC
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):488-502. PubMed ID: 23994244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled release and reversal of multidrug resistance by co-encapsulation of paclitaxel and verapamil in solid lipid nanoparticles.
    Baek JS; Cho CW
    Int J Pharm; 2015 Jan; 478(2):617-24. PubMed ID: 25510604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue distribution of borneol-modified ganciclovir-loaded solid lipid nanoparticles in mice after intravenous administration.
    Ren J; Zou M; Gao P; Wang Y; Cheng G
    Eur J Pharm Biopharm; 2013 Feb; 83(2):141-8. PubMed ID: 23201052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies.
    Martins S; Tho I; Reimold I; Fricker G; Souto E; Ferreira D; Brandl M
    Int J Pharm; 2012 Dec; 439(1-2):49-62. PubMed ID: 23046667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amsacrine analog-loaded solid lipid nanoparticle to resolve insolubility for injection delivery: characterization and pharmacokinetics.
    Fang YP; Chuang CH; Wu PC; Huang YB; Tzeng CC; Chen YL; Liu YT; Tsai YH; Tsai MJ
    Drug Des Devel Ther; 2016; 10():1019-28. PubMed ID: 27019595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evading P-glycoprotein mediated-efflux chemoresistance using Solid Lipid Nanoparticles.
    Cavaco MC; Pereira C; Kreutzer B; Gouveia LF; Silva-Lima B; Brito AM; Videira M
    Eur J Pharm Biopharm; 2017 Jan; 110():76-84. PubMed ID: 27810470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles.
    Silva AC; Kumar A; Wild W; Ferreira D; Santos D; Forbes B
    Int J Pharm; 2012 Oct; 436(1-2):798-805. PubMed ID: 22867992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier.
    Dal Magro R; Ornaghi F; Cambianica I; Beretta S; Re F; Musicanti C; Rigolio R; Donzelli E; Canta A; Ballarini E; Cavaletti G; Gasco P; Sancini G
    J Control Release; 2017 Mar; 249():103-110. PubMed ID: 28153761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery.
    Jose S; Anju SS; Cinu TA; Aleykutty NA; Thomas S; Souto EB
    Int J Pharm; 2014 Oct; 474(1-2):6-13. PubMed ID: 25102112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of solid lipid nanoparticles for sustained drug release.
    Attama AA; Umeyor CE
    Ther Deliv; 2015; 6(6):669-84. PubMed ID: 26149784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid lipid nanoparticles for delivery of andrographolide across the blood-brain barrier: in vitro and in vivo evaluation.
    Graverini G; Piazzini V; Landucci E; Pantano D; Nardiello P; Casamenti F; Pellegrini-Giampietro DE; Bilia AR; Bergonzi MC
    Colloids Surf B Biointerfaces; 2018 Jan; 161():302-313. PubMed ID: 29096375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and cytotoxicity evaluation of repaglinide-loaded binary solid lipid nanoparticles after oral administration to rats.
    Rawat MK; Jain A; Singh S
    J Pharm Sci; 2011 Jun; 100(6):2406-17. PubMed ID: 21491451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment.
    Chirio D; Gallarate M; Peira E; Battaglia L; Muntoni E; Riganti C; Biasibetti E; Capucchio MT; Valazza A; Panciani P; Lanotte M; Annovazzi L; Caldera V; Mellai M; Filice G; Corona S; Schiffer D
    Eur J Pharm Biopharm; 2014 Nov; 88(3):746-58. PubMed ID: 25445304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and cytotoxicity of 2-methoxyestradiol-loaded solid lipid nanoparticles.
    Guo X; Xing Y; Mei Q; Zhang H; Zhang Z; Cui F
    Anticancer Drugs; 2012 Feb; 23(2):185-90. PubMed ID: 22027535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and in vitro, in vivo evaluations of norfloxacin-loaded solid lipid nanopartices for oral delivery.
    Dong Z; Xie S; Zhu L; Wang Y; Wang X; Zhou W
    Drug Deliv; 2011 Aug; 18(6):441-50. PubMed ID: 21554156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baclofen-loaded solid lipid nanoparticles: preparation, electrophysiological assessment of efficacy, pharmacokinetic and tissue distribution in rats after intraperitoneal administration.
    Priano L; Zara GP; El-Assawy N; Cattaldo S; Muntoni E; Milano E; Serpe L; Musicanti C; Pérot C; Gasco MR; Miscio G; Mauro A
    Eur J Pharm Biopharm; 2011 Sep; 79(1):135-41. PubMed ID: 21352914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
    Fang JY; Fang CL; Liu CH; Su YH
    Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study).
    Lloret-Linares C; Daali Y; Chevret S; Nieto I; Molière F; Courtet P; Galtier F; Richieri RM; Morange S; Llorca PM; El-Hage W; Desmidt T; Haesebaert F; Vignaud P; Holtzmann J; Cracowski JL; Leboyer M; Yrondi A; Calvas F; Yon L; Le Corvoisier P; Doumy O; Heron K; Montange D; Davani S; Déglon J; Besson M; Desmeules J; Haffen E; Bellivier F
    BMC Pharmacol Toxicol; 2017 Nov; 18(1):70. PubMed ID: 29115994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route.
    Patel S; Chavhan S; Soni H; Babbar AK; Mathur R; Mishra AK; Sawant K
    J Drug Target; 2011 Jul; 19(6):468-74. PubMed ID: 20958095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.